Trial Details
COMPLETEDBasic Information
| Clinical ID | c265 |
|---|---|
| Identifier | NCT04885920 |
| Trial Title | A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohns Disease|Colitis, Ulcerative |
| Interventions | - |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Osijek |
| Country/Region | Croatia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2022-02-22 |
|---|---|
| Primary Completion Date | 2024-03-12 |
| Completion Date | 2024-03-12 |